Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Los Angeles, California 90073


Purpose:

The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition. Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.


Criteria:

Inclusion Criteria: - Diagnosed with schizophrenia disorder by a DSM IV. - Competent to sign informed consent - No history of poor response to Risperdal and Zyprexa - No organic brain disease Exclusion Criteria: - Mental retardation or any chronic medical illness which results in the patient not being appropriate for a switch to Risperdal or Zyprexa.


NCT ID:

NCT00108368


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Los Angeles, California 90073
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 16, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.